Page 51 - Read Online
P. 51

Page 10 of 10                                                 Chen et al. Hepatoma Res 2018;4:4  I  http://dx.doi.org/10.20517/2394-5079.2017.50

               34.   Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int 2012;32:1333-41.
               35.   Liu TT, Fang Y, Xiong H, Chen TY, Ni ZP, Luo JF, Zhao NQ, Shen XZ. A case-control study of the relationship between hepatitis B
                   virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World J Gastroenterol 2008;14:3059-63.
               36.   Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virus mutations and the risk of hepatocellular
                   carcinoma: a meta-analysis. J Natl Cancer Inst 2009;101:1066-82.
               37.   Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Woqan GN, Groopman JD. A follow-up study of urinary markers of
                   aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10.
               38.   Lu P, Wang J, Zhang Q, Wu Y, Sun Y, Chen T. Longitudinal study of aflatoxin exposure in the development of primary liver cancer in
                   patients with chronic hepatitis. Natl Med J China 2010;90:1665-9.
               39.   Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, Wang JB, Wu Y, Kensler TW, Vogelstein B, Groopman JD. Specific p53 mutations
                   detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res
                   2001;61:33-5.
               40.   Luo H, Wan S, Lu P, Liu Y, Wang J, Jin Y, Wu Y, Qian G. The p53 overexpression in Qidong liver cancer tissues analysed
                   immunohistochemically. Tumor 2002;22:101-3.
               41.   Rashid A, Wang JS, Qian GS, Lu BX, Hamilton SR, Groopman JD. Genetic alterations in hepatocellular carcinomas: association
                   between loss of chromosome 4q and p53 gene mutations. Br J Cancer 1999;80:59-66.
               42.   Jackson PE, Kuang SY, Wang JB, Strickland PT, Muñoz A, Kensler TW, Qian GS, Groopman JD. Prospective detection of codon 249
                   mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 2003;24:1657-63.
               43.   Chen JG, Egner PA, Ng D, Jacobson LP, Muñoz A, Zhu YR, Qian GS, Wu F, Yuan JM, Groopman JD, Kensler TW. Reduced aflatoxin
                   exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res (Phila) 2013;6:1038-45.
   46   47   48   49   50   51   52   53   54   55   56